Navigation Links
Consensus on "Combination Therapy" for Breast Cancer ,,

Breast cancer is the commonest cancer among women in the world. There has been some on going controversy on certain aspects of treatment modalities of this cancer. Besides surgery there are other options to treat the cancer including radiation, chemotherapy and hormonal therapy. Now at a three-day conference at the National Institutes of Health doctors have agreed to a consensus on the combination therapy for the cancer. Dctors have agreed that the combination therapy for women with breast cancer is beneficial. Depending on a woman's stage of the disease the experts recommend surgery along with either chemotherapy or hormonal therapy.



To help in the decision-making, experts came up with their own recommendations as follows:

1. Women whose breast tumors contain estrogen receptors, regardless of other factors, are recommended to use hormonal therapy. The panel suggests five years of drug-Tamoxifen as the standard hormonal adjuvant therapy. Hormonal therapy is not suggested for women whose tumors do not have hormone receptors.

2. Women who have had a mastectomy and have four or more cancerous lymph nodes can best benefit from post-surgical radiation. At this point the panel says there is not enough evidence that women with three or fewer cancerous lymph nodes benefit from radiation.

Patricia Eifel of Anderson Cancer Center in Houston, said to one of the medical news agencies that, "Women with breast cancer have more treatment options and a better chance of surviving their disease than ever before. At the same time, making treatment decisions has become a more complex process for them and their physicians due to a growing list of effective options."
'"/>




Page: 1

Related medicine news :

1. Climate Talks Reach Consensus in Bangkok
2. Women Alerted against "Natural Hormone Replacement Therapy"
3. Breast cancer treatment to be determined by gene test
4. Breast Feeding prevents obesity later on in life
5. Breast milk is essential
6. Breast Cancer Surgery Causes Psychological problems
7. Breast cancer evidence
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Breast screening among diabetic women
10. Breast feeding can alter hormones
11. Diet, Sunlight connected to Breast Cancer Risk
Post Your Comments:
(Date:12/2/2008).... 2 TYRX, Inc., a leader in the de...-device products, today announced the appointment ...esponsible for commercial operations. , , M...e medical device industry. Mr. Elliot joins TYRX f...on providing laser-based antimicrobial and vascula...
(Date:12/2/2008)...-- Services form an integral part of most of,orig... has therefore become,essential for service provi...ket to remain competitive and constantly improve t... (Logo: http://www.newscom.com/cgi-bin/prnh...t & Sullivan ( http://www.medicalimaging.frost...
(Date:12/2/2008)...na Health and Solutions Medical Billing Team Up To...s in a Cloud" as a SaaS Application. , ...mber 2, 2008 -- Making medical insurance claims is...st phase of a "Claims in a Cloud" softwa...delling partners Xena Health and Solutions Medical...
(Date:12/2/2008)...es your over-the-phone interpretation vendor conti...ompleted the call? , Wash...rld of over-the-phone interpretation (OPI), every ...r one minute can add up over the course of a billi...anization employs an over-the-phone interpretation...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Corporate Modelling Partners Start Selling BPM in Cloud Service 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3
...nder the age of 65 who lacked health insurance for...2 percent in 2005//. The proportion of uninsured r... County to a high of 27.5 percent in Tyrrell Count...icularly acute problem in Eastern North Carolina; ...
...e occurrence of multiple sclerosis (MS) among wome...mained// stable. Data from a voluntary MS registr... men in the U.S. had multiple sclerosis, by 2000, ...ong women, University of Alabama professor of bios...
...model of infantile spasms, improving the likelihoo...oung children// who suffer from these catastrophic...ile spasms are a specific type of epilepsy seizure...The disorder involves a sudden bending forward and...
...ty School of Medicine has helped confirm the relia...ch// individual's genetic makeup. The Stanford gr...e that the genetic test can identify patients who ...is from chronic hepatitis C infection. That means ...
Other Medicine News:Health News:Number of Uninsured in North Carolina on the Rise 2Health News:Women More Vulnerable to Multiple Sclerosis, Research Shows 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 3
(Date:12/1/2008)...Prox1 gene is a two-way switch that, if turned off...ammed so that they lose their identity and become ...IS, Tenn., Dec. 1 Scie...ve discovered that a certain differentiated cell t...uires the constant expression of a gene called Pr...
(Date:12/1/2008)...ecember 1 Following a,R... to procure an MVA-based,third generation smallp...Canada, on behalf of the Canadian Department of Na...n Nordic for the delivery of IMVAMUNE(R). , ...) as part of the,country,s bio-preparedness progr...
(Date:12/1/2008)...wire-FirstCall/ -- Vical Incorporated (Nasdaq: V...n milestone payment from Merck & Co., Inc. bas...ical trial of an investigational plasmid DNA (pDNA...n Vical,s DNA gene delivery technology and encodes...TERT is the subject of separate license agreement....
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 1Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 3Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Best treatment for MS may depend on disease subtype 23072 1Best treatment for MS may depend on disease subtype 23072 2Best treatment for MS may depend on disease subtype 23072 3The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 1The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 2The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 3
...S WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB:...,drugs for HIV and Multiple Sclerosis has today an...harm, has received notification of,acceptance of i...n,Immunology special conference issue., The articl...y,for Multiple Sclerosis; a review of the literatu...
...aplatin Demonstrated Statistically,Significant Imp...BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- P...nced additional data from,the double-blind, random... SPARC trial (Satraplatin and Prednisone Against,R...e 22nd Annual,European Association of Urology Cong...
Other Medicine Technology:Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
... Enzymelinked Immunosorbent Assays(ELISA) is inten...on of IgG antibody to Measles Rubeola) virus in hu...or the determination of immune status. Paired sera...rate seroconversion or a significant rise in antib...
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo
Medicine Products: